Scheimpflug imaging is effective for detecting narrow angles

Article

Data recently published in Eye has demonstrated that anterior chamber volume (ACV) measurements taken with Scheimpflug imaging is better for detecting narrow angles than spectral domain anterior segment optical coherence tomography (SD-ASOCT).

Data recently published in Eye has demonstrated that anterior chamber volume (ACV) measurements taken with Scheimpflug imaging is better for detecting narrow angles than spectral domain anterior segment optical coherence tomography (SD-ASOCT).

A team led by Dr D.S. Grewal, Department of Ophthalmology, Northwestern University of Feinberg School of Medicine, Chicago, USA, conducted a prospective, cross-sectional, observational study on 265 eyes of 265 patients. Each patient underwent sequential Schiempflug, SD-ASOCT imaging and gonioscopy. The outcome measures included area under receiver operating characteristic curve (AUC), sensitivity, specificity, and likelihood ratios (LRs). These were used to measure the performance of ACV, anterior chamber depth (ACD), angle opening distance (AOD500), and trabecular-iris space area (TISA500) in detecting narrow angles.

Of the eyes studied, 28 eyes were identified as narrow angles on gonioscopy. When detecting narrow angles ACD and ACV performed similarly to each other and significantly better than the nasal and temporal for both AOD500 and TISA500.

The findings demonstrated overall sensitivity and specificity for detecting narrow angles of ACV was 90% and 88%, respectively. The positive and negative LRs were 8.63 and 0.11, respectively. The use of Scheimpflug imaging to perform ACV measurements is more successful than AOD500 and TISA500 for the detection of narrow angles.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.